FDA — authorised 10 August 2001
- Marketing authorisation holder: SCIOS LLC
- Status: approved
FDA authorised Natrecor on 10 August 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 10 August 2001.
SCIOS LLC holds the US marketing authorisation.